# SBRT for Close or Positive Margins After Resection of Pancreatic Adenocarcinoma

> **NCT01357525** · NA · COMPLETED · sponsor: **David A. Clump, MD, PhD** · enrollment: 50 (actual)

## Conditions studied

- Adenocarcinoma of the Pancreas

## Interventions

- **RADIATION:** Stereotactic Body Radiation Therapy (SBRT)

## Key facts

- **NCT ID:** NCT01357525
- **Lead sponsor:** David A. Clump, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02-06
- **Primary completion:** 2018-04-01
- **Final completion:** 2018-06-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2021-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01357525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01357525, "SBRT for Close or Positive Margins After Resection of Pancreatic Adenocarcinoma". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01357525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*